サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1771308

製造実行システム市場：業界動向と世界の予測 - 展開タイプ別、エンドユーザー別、主要地域別

Manufacturing Execution System Market: Industry Trends and Global Forecasts - Distribution by Type of Deployment, Type of End-User and Key Geographical Regions

出版日
ページ情報
英文 119 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
製造実行システム市場：業界動向と世界の予測 - 展開タイプ別、エンドユーザー別、主要地域別
出版日: 2025年07月15日
発行: Roots Analysis
ページ情報: 英文 119 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の製造実行システム市場：概要

世界の製造実行システムの市場規模は、2035年までの予測期間中に16.02%のCAGRで拡大し、現在の39億9,000万米ドルから2035年までに204億6,000万米ドルに成長すると予測されています。

市場セグメンテーションでは、市場規模および市場機会を以下のパラメータで区分しています：

展開タイプ

  • クラウド
  • 企業データセンター
  • ハイブリッド
  • オンプレミス

エンドユーザー

  • ライフサイエンス/バイオテクノロジー企業
  • 医療機器プロバイダー
  • 製薬会社、その他

主要地域

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・北アフリカ

世界の製造実行システム市場：成長と動向

長年にわたり、ヘルスケア産業は大幅な成長を遂げており、進化する市場情勢の中で関連性と競争力を維持するために、製造業者は新しい技術とツールの導入が不可欠となっています。製造実行システムは、ヘルスケア業界において長期的な競争優位性を獲得する上で重要な役割を果たしています。製造実行システムは、複雑な製造工程のさまざまなプロセスを接続、監視、同期化する動的な情報システムです。MESシステムは、工場の生産性と効率を向上させるとともに、製造プロセス全体の柔軟性と俊敏性を高めます。また、規制ガイドラインに準拠するプロセスを簡素化し、ヘルスケア企業が製造プロセスで高い品質基準を維持することを容易にします。

Manufacturing Execution System Market-IMG1

近年、いくつかのヘルスケア利害関係者は、製造実行システムを生産ラインに組み込む取り組みを積極的に行っています。さらに、この領域に携わる企業は、モノのインターネット（IoT）や人工知能（AI）などの先進技術を統合して、さまざまなソースから大量のデータを収集・分析し、洞察、予測、行動の形で価値を生み出しています。ヘルスケア産業が製造実行システムに目を向け、生産ラインに関するデータ主導の意思決定を行うことで、産業プロセスの将来は、より高い効率性とより良い成長機会を約束します。

世界の製造実行システム市場：主要インサイト

当レポートでは、世界の製造実行システム市場の現状を掘り下げ、産業界における潜在的な成長機会を特定しています。主な調査結果は以下の通りです。

  • 現在、ヘルスケア分野の生産プロセスを監視、追跡、制御するために、世界中で75社以上が製造実行システム（MES）を提供していると主張しています。
  • 利害関係者は、製薬、ライフサイエンス/バイオテクノロジー、医療機器業界向けに、さまざまなライセンスモデルを通じて、数多くの種類のソフトウェアと統合したMESを提供しています。
  • MESプロバイダーの85%以上がサブスクリプションモデルでサービスを提供しており、医療機器業界はこうしたサービスの有力なエンドユーザーとして浮上しています。
  • ERPとPLMは最も顕著な統合ソフトウェアとして浮上しており、50%近くの利害関係者が複数のソフトウェアと統合したMESを提供しています。
  • 15%近くの利害関係者が、すべてのエンドユーザーにMESを提供していると主張しており、主な例としてはAtachi Systems、Dassault Systemes、Epicor、GE Digital、Infor、Tulipなどが挙げられます。
  • 世界中のクライアントの進化するニーズに対応するため、利害関係者はさまざまな地域に進出しています。
Manufacturing Execution System Market-IMG2
  • 利害関係者の関心が高まっていることは、パートナーシップ活動の増加からも明らかであり、事実、過去2年間で最も多くの提携が結ばれています。
  • 競争優位性を築くため、製造実行システムプロバイダーは既存の能力を積極的にアップグレードし、それぞれのサービス／製品の提供をさらに強化しています。
  • 当社独自の価値創造フレームワークでは、この分野の新興プレーヤーがMESポートフォリオを強化するために統合しなければならない主なツールやテクノロジーをハイライトしています。
  • 同市場は、今後10年間で16%以上の健全な成長が見込まれており、その機会は様々な導入形態、エンドユーザー、様々な地域に分散していると思われます。
Manufacturing Execution System Market-IMG3

世界の製造実行システム市場：主要セグメント

市場は導入タイプ別に、クラウド、企業データセンター、ハイブリッド、オンプレミスに区分されます。現在のところ、クラウドベースのMESソリューションに対する需要の高まりにより、クラウドセグメントが世界の製造実行システム市場で最大（～69%）のシェアを占めています。しかし、ハイブリッドセグメントは予測期間中により高いCAGRで成長すると予想されます。

エンドユーザーのタイプ別に、市場はライフサイエンス/バイオテクノロジー企業、医療機器プロバイダー、製薬企業、その他に区分されます。現在、医療機器プロバイダーセグメントが製造実行システム市場で最も高い割合（~51%）を占めています。さらに、ライフサイエンス/バイオテクノロジー企業セグメントは、バッチ生産管理、追跡、材料や製品のトレースを支援するMESへの依存度が高いため、相対的に高いCAGRで成長する可能性が高いです。

主要地域別に見ると、市場は北米、欧州、アジア太平洋、中東・アフリカ、ラテンアメリカ、その他の地域に区分されます。現在、欧州（～41％）が製造実行システム市場を独占し、最大の収益シェアを占めています。しかし、アジア太平洋地域の市場は予測期間中に16.8%という高いCAGRで成長すると予想されています。

製造実行システム市場における参入企業例

  • Andea
  • Critical Manufacturing
  • Dassault Systemes
  • GE Digital
  • Infor
  • Korber
  • Rockwell Automation

当レポートでは、世界の製造実行システム市場について調査し、市場の概要とともに、展開タイプ別、エンドユーザー別動向、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 イントロダクション

  • 製造実行システムの概要
  • 製造実行システムの中核機能
  • 製造実行システムの導入モデル
  • 製造実行システムが提供するメリット
  • 製造実行システムに関連する課題
  • 異なるオペレーション向けの製造実行システムの統合
  • 結論

第4章 市場情勢

第4章 ヘルスケアにおける製造実行システムプロバイダー：市場概要

  • ヘルスケアの製造実行システムプロバイダー一覧
  • 設立年別分析
  • 企業規模別分析
  • 本社所在地別分析
  • 展開タイプ別の分析
  • ソフトウェア統合別分析
  • ライセンスタイプ別の分析
  • エンドユーザータイプ別分析
  • 主な特徴別分析
  • 提供されるサービスタイプ別の分析
  • 取得した品質認証別分析

第5章 重要な洞察

第6章 パートナーシップとコラボレーション

第7章 企業競争力分析

  • ヘルスケアにおける製造実行システムプロバイダー：企業競争力分析
  • 前提と主要なパラメータ
  • 調査手法
  • ポートフォリオの強さのベンチマーク
  • パートナーシップ活動のベンチマーキング
  • 企業競争力分析：超大手企業
  • 企業競争力分析：大手企業
  • 企業競争力分析：中規模企業
  • 企業競争力分析：小規模企業

第8章 企業プロファイル

  • Andea
  • Critical Manufacturing
  • Dassault Systemes
  • GE Digital
  • Infor
  • Korber
  • Rockwell Automation

第9章 価値創造フレームワーク：製造実行システムの未充足ニーズに対応するための戦略ガイド

  • ヘルスケア業界における製造実行システムに対する満たされていないニーズ
  • 主要な前提と調査手法
  • 主要なツールとテクノロジー
  • イノベーションの程度とそれに伴うリスク
  • 結論

第10章 市場予測

  • 主要な前提と予測調査手法
  • 予測される市場セグメント
  • ヘルスケア市場における製造実行システムプロバイダー（2035年まで）
  • ヘルスケア市場における製造実行システムプロバイダー：展開タイプ別分析（2035年まで）
  • ヘルスケア市場における製造実行システムプロバイダー：エンドユーザー別分析（2035年まで）
  • ヘルスケア市場における製造実行システムプロバイダー：地域分析（2035年まで）

第11章 エグゼクティブ洞察

第12章 付録I：その他の図

第13章 付録II：表形式データ

第14章 付録III：企業一覧

図表

List of Tables

  • Table 4.1. Manufacturing Execution System Providers in Healthcare: Information on Year of Establishment, Headquarters, Company Size and Name of Solution
  • Table 4.2. Manufacturing Execution System Providers in Healthcare: Information on Type of Deployment, Integrating Software, Type of License, Type of End User, Key Features, Type of Service(s) Offered and Quality Certifications Received
  • Table 4.3. Manufacturing Execution System Providers in Healthcare: Key Features, Type of Service(s) Offered and Quality Certifications Received
  • Table 6.1. Manufacturing Execution System Providers in Healthcare: Partnerships and Collaborations
  • Table 13.1. Manufacturing Execution System Providers in Healthcare Distribution by Year of Establishment
  • Table 13.2. Manufacturing Execution System Providers in Healthcare: Distribution by Company Size
  • Table 13.3. Manufacturing Execution System Providers in Healthcare: Distribution by Location of Headquarters
  • Table 13.4. Manufacturing Execution System Providers in Healthcare: Distribution by Type of Deployment
  • Table 13.5. Manufacturing Execution System Providers in Healthcare: Distribution by Integrating Software
  • Table 13.6. Manufacturing Execution System Providers in Healthcare: Distribution by Type of License
  • Table 13.7. Manufacturing Execution System Providers in Healthcare: Distribution by Type of End User
  • Table 13.8. Manufacturing Execution System Providers in Healthcare: Distribution by Key Features
  • Table 13.9. Manufacturing Execution System Providers in Healthcare: Distribution by Type of Service(s) Offered
  • Table 13.10. Partnerships and Collaborations: Distribution by Year of Partnership
  • Table 13.11. Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 13.12. Partnerships and Collaborations: Distribution by Year and Type of Partnership
  • Table 13.13. Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
  • Table 13.14. Partnerships and Collaborations: Key Players by Number of Partnerships
  • Table 13.15. Partnerships and Collaborations: Distribution by Type of Partner
  • Table 13.16. Partnerships and Collaborations: Distribution by Country
  • Table 13.17. Partnerships and Collaborations: Distribution by Region
  • Table 13.18. Intercontinental and Intracontinental Deals
  • Table 13.19. Manufacturing Execution System Providers in Healthcare Market: Distribution by Type of Deployment, Till 2035
  • Table 13.20. Manufacturing Execution System Providers in Healthcare Market for Cloud Solutions (USD Billion)
  • Table 13.21. Manufacturing Execution System Providers in Healthcare Market for Corporate Datacenter Solutions (USD Billion)
  • Table 13.22. Manufacturing Execution System Providers in Healthcare Market for Hybrid Solutions (USD Billion)
  • Table 13.23. Manufacturing Execution System Providers in Healthcare Market for On Premise Solutions (USD Billion)
  • Table 13.24. Manufacturing Execution System Providers in Healthcare Market: Distribution by Type of End User, Till 2035
  • Table 13.25. Manufacturing Execution System Providers in Healthcare Market for Life science / Biotechnology Companies (USD Billion)
  • Table 13.26. Manufacturing Execution System Providers in Healthcare Market for Medical Device Providers (USD Billion)
  • Table 13.27. Manufacturing Execution System Providers in Healthcare Market for Pharmaceutical Companies (USD Billion)
  • Table 13.28. Manufacturing Execution System Providers in Healthcare Market for Other End Users (USD Billion)
  • Table 13.29. Manufacturing Execution System Providers in Healthcare Market: Distribution by Geography, Till 2035
  • Table 13.30. Manufacturing Execution System Providers in Healthcare Market in North America, Till 2035
  • Table 13.31. Manufacturing Execution System Providers in Healthcare Market in Europe, Till 2035
  • Table 13.32. Manufacturing Execution System Providers in Healthcare Market in Asia, Till 2035
  • Table 13.33. Manufacturing Execution System Providers in Healthcare Market in Latin America, Till 2035
  • Table 13.34. Manufacturing Execution System Providers in Healthcare Market in MENA, Till 2035
  • Table 13.35. Manufacturing Execution System Providers in Healthcare Market in Rest of the World, Till 2035

List of Figures

  • Figure 3.4. Integration of Manufacturing Execution Systems for Different Operations
  • Figure 4.1. Manufacturing Execution System Providers in Healthcare Distribution by Year of Establishment
  • Figure 4.2. Manufacturing Execution System Providers in Healthcare: Distribution by Company Size
  • Figure 4.3. Manufacturing Execution System Providers in Healthcare: Distribution by Location of Headquarters
  • Figure 4.4. Manufacturing Execution System Providers in Healthcare: Distribution by Type of Deployment
  • Figure 4.5. Manufacturing Execution System Providers in Healthcare: Distribution by Integrating Software
  • Figure 4.6. Manufacturing Execution System Providers in Healthcare: Distribution by Type of License
  • Figure 4.7. Manufacturing Execution System Providers in Healthcare: Distribution by Type of End User
  • Figure 4.8. Manufacturing Execution System Providers in Healthcare: Distribution by Key Features
  • Figure 4.9. Manufacturing Execution System Providers in Healthcare: Distribution by Type of Service(s) Offered
  • Figure 5.1. Key Insights: Distribution by Year of Establishment and Region of Headquarters
  • Figure 5.2. Key Insights: Distribution by Company Size and Type of Deployment
  • Figure 5.3. Key Insights: Distribution by Type of License and End User
  • Figure 5.4. Key Insights: Distribution by Company Size and Key Features
  • Figure 5.5. Key Insights: Distribution by Year of Establishment, Company Size, Type of Deployment and Quality Certifications Received
  • Figure 6.1. Partnerships and Collaborations: Distribution by Year of Partnership
  • Figure 6.2. Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 6.3. Partnerships and Collaborations: Distribution by Year and Type of Partnership
  • Figure 6.4. Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
  • Figure 6.5. Partnerships and Collaborations: Key Players by Number of Partnerships
  • Figure 6.6. Partnerships and Collaborations: Distribution by Type of Partner
  • Figure 6.7. Partnerships and Collaborations: Distribution by Country
  • Figure 6.8. Partnerships and Collaborations: Distribution by Region
  • Figure 6.9. Intercontinental and Intracontinental Deals
  • Figure 7.1. Company Competitiveness Analysis: Benchmarking of Portfolio Strength
  • Figure 7.2. Company Competitiveness Analysis: Benchmarking of Partnership Activity
  • Figure 7.3. Company Competitiveness Analysis: Very Large Players
  • Figure 7.4. Company Competitiveness Analysis: Large Players
  • Figure 7.5. Company Competitiveness Analysis: Mid-Sized Players
  • Figure 7.6. Company Competitiveness Analysis: Small Players
  • Figure 9.1. Value Creation Framework: Trends in Research Activity related to Integration of Key Tools and Technologies with Manufacturing Execution System
  • Figure 9.2. Value Creation Framework: Trends in Intellectual Property related to Integration of Key Tools and Technologies with Manufacturing Execution System
  • Figure 9.3. Value Creation Framework: Extent of Innovation versus Associated Risk Matrix
  • Figure 9.4. Value Creation Framework: Comparison of Key Tools / Technologies
  • Figure 10.1. Manufacturing Execution System Providers in Healthcare Market: Distribution by Type of Deployment, Till 2035
  • Figure 10.2. Manufacturing Execution System Providers in Healthcare Market for Cloud Solutions (USD Billion)
  • Figure 10.3. Manufacturing Execution System Providers in Healthcare Market for Corporate Datacenter Solutions (USD Billion)
  • Figure 10.4. Manufacturing Execution System Providers in Healthcare Market for Hybrid Solutions (USD Billion)
  • Figure 10.5. Manufacturing Execution System Providers in Healthcare Market for On Premise Solutions (USD Billion)
  • Figure 10.6. Manufacturing Execution System Providers in Healthcare Market: Distribution by Type of End User, Till 2035
  • Figure 10.7. Manufacturing Execution System Providers in Healthcare Market for Life science / Biotechnology Companies (USD Billion)
  • Figure 10.8. Manufacturing Execution System Providers in Healthcare Market for Medical Device Providers (USD Billion)
  • Figure 10.9. Manufacturing Execution System Providers in Healthcare Market for Pharmaceutical Companies (USD Billion)
  • Figure 10.10. Manufacturing Execution System Providers in Healthcare Market for Other End Users (USD Billion)
  • Figure 10.11. Manufacturing Execution System Providers in Healthcare Market: Distribution by Geography, Till 2035
  • Figure 10.12. Manufacturing Execution System Providers in Healthcare Market in North America, Till 2035
  • Figure 10.13. Manufacturing Execution System Providers in Healthcare Market in Europe, Till 2035
  • Figure 10.14. Manufacturing Execution System Providers in Healthcare Market in Asia, Till 2035
  • Figure 10.15. Manufacturing Execution System Providers in Healthcare Market in Latin America, Till 2035
  • Figure 10.16. Manufacturing Execution System Providers in Healthcare Market in MENA, Till 2035
  • Figure 10.17. Manufacturing Execution System Providers in Healthcare Market in Rest of the World, Till 2035
目次
Product Code: RA100374

GLOBAL MANUFACTURING EXECUTION SYSTEM MARKET: OVERVIEW

As per Roots Analysis, the global manufacturing execution system market is estimated to grow from USD 3.99 billion in the current year to USD 20.46 billion by 2035, at a CAGR of 16.02% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Deployment

  • Cloud
  • Corporate Data Center
  • Hybrid
  • On Premise

Type of End-User

  • Life Science / Biotechnology Companies
  • Medical Device Providers
  • Pharmaceutical Companies and Others

Key Geographical Regions

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and North Africa

GLOBAL MANUFACTURING EXECUTION SYSTEM MARKET: GROWTH AND TRENDS

Over the years, the healthcare industry has undergone substantial growth, making it essential for manufacturers to adopt new technologies and tools in order to remain relevant and competitive in the evolving market landscape. Manufacturing execution systems play a crucial role in achieving long term competitive advantages in the healthcare industry. Manufacturing execution system is a dynamic information system that connects, monitors, and synchronizes various processes of complex manufacturing processes. MES system enables enhanced plant productivity and efficiency along with increased flexibility and agility across the manufacturing processes. It also simplifies the process of complying with regulatory guidelines and facilitates healthcare companies in maintaining high quality standards during the production process.

Manufacturing Execution System Market - IMG1

In recent years, several healthcare stakeholders have actively undertaken initiatives to incorporate manufacturing execution systems into their production lines. In addition, players engaged in this domain are integrating advanced technologies, including internet of thing (IOT) and artificial intelligence (AI) to collect and analyze large volume of data from various sources and to produce value in the form of insights, predictions, and actions. With the healthcare industry turning towards manufacturing execution systems to make data-driven decisions about their production lines, the future of industrial processes promises greater efficiency and better opportunities for growth.

GLOBAL MANUFACTURING EXECUTION SYSTEM MARKET: KEY INSIGHTS

The report delves into the current state of the global manufacturing execution system market and identifies potential growth opportunities within industry. Some key findings from the report include:

  • At present, more than 75 companies across the globe claim to offer manufacturing execution systems (MES) in order to monitor, track and control the production process in the healthcare sector.
  • Stakeholders are offering MES, integrated with numerous types of software, through different licensing models to serve the pharmaceutical, life science / biotechnology and medical device industries.
  • Over 85% of the MES providers offer such services via subscription models; the medical device industry has emerged as a prominent end user for such services.
  • ERP and PLM have emerged as the most prominent integration software; nearly 50% of stakeholders offer MES integrated with more than one type of software.
  • Nearly 15% stakeholders claim to offer MES for all end users; prominent examples include Atachi Systems, Dassault Systemes, Epicor, GE Digital, Infor and Tulip.
  • In order to cater to the evolving needs of clients across the world, stakeholders have established a presence across different regions; Europe has emerged as the key hub, featuring the highest number of MES providers.
Manufacturing Execution System Market - IMG2
  • The growing interest of stakeholders is also evident from the rise in partnership activity; in fact, the maximum number of collaborations were inked in the last two years.
  • In pursuit of building a competitive edge, manufacturing execution system providers are actively upgrading their existing capabilities to further enhance their respective service / product offerings.
  • Our proprietary value creation framework highlights the key tools and technologies that emerging players in this domain must integrate in order to augment their MES portfolio.
  • The market is expected to witness a healthy growth of over 16% in the coming decade; the opportunity is likely to be well distributed across various type of deployments, end users and different regions.
Manufacturing Execution System Market - IMG3

GLOBAL MANUFACTURING EXECUTION SYSTEM MARKET: KEY SEGMENTS

Cloud Segment Occupies the Largest Share of the Manufacturing Execution System Market

Based on the type of deployment, the market is segmented into cloud, corporate datacenter, hybrid and on-premises. At present, the cloud segment holds the maximum (~69%) share of the global manufacturing execution system market due to the growing demand for cloud-based MES solutions. However, the hybrid segment is expected to grow at a higher CAGR during the forecast period.

By Type of End-User, Life Science / Biotechnology Companies is the Fastest Growing Segment of the Global Manufacturing Execution System Market

Based on the type of end-user, the market is segmented into life science / biotechnology companies, medical device providers, pharmaceutical companies and others. Currently, the medical device providers segment captures the highest proportion (~51%) of the manufacturing execution system market. Further, the life science / biotechnology companies' segment is likely to grow at a relatively higher CAGR as the companies highly rely on MES that aid in managing batch production, tracking, and tracing materials and products.

Europe Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, Latin America, and the rest of the world. Currently, Europe (~41%) dominates the manufacturing execution system market and accounts for the largest revenue share. However, the market in Asia-Pacific is expected to grow at a higher CAGR of 16.8% during the forecast period.

Example Players in the Manufacturing Execution System Market

  • Andea
  • Critical Manufacturing
  • Dassault Systemes
  • GE Digital
  • Infor
  • Korber
  • Rockwell Automation

PRIMARY RESEARCH OVERVIEW

The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders. The research report features detailed transcripts of interviews conducted with the following industry stakeholders:

  • Chief Executive Officer, Company A
  • Chief Marketing Officer, Company B
  • Director of Sales, Company C

GLOBAL MANUFACTURING EXECUTION SYSTEM MARKET

  • Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global manufacturing execution system market, focusing on key market segments, including [A] type of deployment, [B] type of end-user and [C] key geographical regions.
  • Market Landscape: A comprehensive evaluation of manufacturing execution system companies in the healthcare industry, considering various parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters, [D] type of deployment, [E] integrating MES software, [F] type of license, [G] type of end-user, [H] key features, [I] type of service(s) offered and [J] quality certifications received.
  • Key Insights: An in-depth analysis of manufacturing execution system market trends using five schematic representations, including [A] a detailed analysis, based on year of establishment and region of headquarters, [B] an analysis, based on company size and type of deployment, [C] a comprehensive analysis, based on type of license and end-user, [D] an analysis, based on company size and key features, and [E] a 4D bubble chart comparing the players engaged in MES market.
  • Partnerships and Collaborations: An in-depth analysis of the deals inked by stakeholders in this domain, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] type of partner, [D] key players (in terms of the number of partnerships signed) and [E] geographical distribution of partnership activity.
  • Company Competitiveness Analysis: An insightful competitive analysis of manufacturing execution system providers in the healthcare industry, examining factors, such as [A] product portfolio strength, [B] competitive index and [C] partnership strength.
  • Company Profiles: In-depth profiles of companies engaged in the manufacturing execution system industry, focusing on [A] company overview and [B] recent developments and an informed future outlook.
  • Value Creation Framework: An insightful framework depicting the implementation of several advanced tools and technologies, such as [A] artificial intelligence, [B] cloud computing, [C] internet of things and [D] machine learning.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How many companies are currently engaged in this market?
  • Which are the leading companies in this market?
  • What factors are likely to influence the evolution of this market?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

  • Complimentary PPT Insights Packs
  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with Research Team
  • Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
    • 1.2.1. Research Assumptions
    • 1.2.2. Project Methodology
    • 1.2.3. Forecast Methodology
    • 1.2.4. Robust Quality Control
    • 1.2.5. Key Considerations
      • 1.2.5.1. Demographics
      • 1.2.5.2. Economic Factors
      • 1.2.5.3. Government Regulations
      • 1.2.5.4. Supply Chain
      • 1.2.5.5. COVID Impact / Related Factors
      • 1.2.5.6. Market Access
      • 1.2.5.7. Healthcare Policies
      • 1.2.5.8. Industry Consolidation
  • 1.3 Key Questions Answered
  • 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Overview of Manufacturing Execution Systems
  • 3.2. Core Function of Manufacturing Execution Systems
  • 3.3. Deployment Models of Manufacturing Execution Systems
  • 3.4. Benefits Offered by Manufacturing Execution Systems
  • 3.5. Challenges Associated with Manufacturing Execution Systems
  • 3.6. Integration of Manufacturing Execution Systems for Different Operations
  • 3.7. Concluding Remarks

4. MARKET LANDSCAPE

4.1. Manufacturing Execution System Providers in Healthcare: Market Overview

  • 4.2. List of Manufacturing Execution System Providers in Healthcare
  • 4.3. Analysis by Year of Establishment
  • 4.4. Analysis by Company Size
  • 4.5. Analysis by Location of Headquarters
  • 4.6. Analysis by Type of Deployment
  • 4.7. Analysis by Integrating Software
  • 4.8. Analysis by Type of License
  • 4.9. Analysis by Type of End User
  • 4.10. Analysis by Key Features
  • 4.11. Analysis by Type of Service(s) Offered
  • 4.12. Analysis by Quality Certifications Received

5. KEY INSIGHTS

  • 5.1. Analysis by Year of Establishment and Region of Headquarters
  • 5.2. Analysis by Company Size and Type of Deployment
  • 5.3. Analysis by Type of License and End User
  • 5.4. Analysis by Company Size and Key Features
  • 5.5. Analysis by Year of Establishment, Company Size, Type of Deployment and Quality Certifications Received (4D Bubble Chart)

6. PARTNERSHIPS AND COLLABORATIONS

  • 6.1. Manufacturing Execution System Providers in Healthcare: Partnerships and Collaborations
  • 6.2. Analysis by Year of Partnership
  • 6.3. Analysis by Type of Partnership
  • 6.4. Analysis by Year of Partnership and Type of Partnership
  • 6.5. Analysis by Type of Partnership and Company Size
  • 6.6. Key Players: Analysis by Number of Partnerships
  • 6.7. Analysis by Type of Partner
  • 6.8. Analysis by Country
  • 6.9. Analysis by Region
  • 6.10. Intercontinental and Intracontinental Deals
  • 6.11. Analysis by Location of Headquarters of Partner
  • 6.12. Analysis by Type of Partnership and Location of Headquarters of Partner

7. COMPANY COMPETITIVENESS ANALYSIS

  • 7.1. Manufacturing Execution System Providers in Healthcare: Company Competitiveness Analysis
  • 7.2. Assumptions and Key Parameters
  • 7.3. Methodology
  • 7.4. Benchmarking of Portfolio Strength
  • 7.5. Benchmarking of Partnership Activity
  • 7.6. Company Competitiveness Analysis: Very Large Players
  • 7.7. Company Competitiveness Analysis: Large Players
  • 7.8. Company Competitiveness Analysis: Mid-Sized Players
  • 7.9. Company Competitiveness Analysis: Small Players

8. COMPANY PROFILES

  • 8.1. Andea
    • 8.1.1. Company Overview
    • 8.1.2. Technology Portfolio
    • 8.1.3. Recent Developments and Future Outlook
  • 8.2. Critical Manufacturing
    • 8.2.1. Company Overview
    • 8.2.2. Technology Portfolio
    • 8.2.3. Recent Developments and Future Outlook
  • 8.3. Dassault Systemes
    • 8.3.1. Company Overview
    • 8.3.2. Technology Portfolio
    • 8.3.3. Recent Developments and Future Outlook
  • 8.4. GE Digital
    • 8.4.1. Company Overview
    • 8.4.2. Technology Portfolio
    • 8.4.3. Recent Developments and Future Outlook
  • 8.5. Infor
    • 8.5.1. Company Overview
    • 8.5.2. Technology Portfolio
    • 8.5.3. Recent Developments and Future Outlook
  • 8.6. Korber
    • 8.6.1. Company Overview
    • 8.6.2. Technology Portfolio
    • 8.6.3. Recent Developments and Future Outlook
  • 8.7. Rockwell Automation
    • 8.7.1. Company Overview
    • 8.7.2. Technology Portfolio
    • 8.7.3. Recent Developments and Future Outlook

9. VALUE CREATION FRAMEWORK: A STRATEGIC GUIDE TO ADDRESS UNMET NEED FOR MANUFACTURING EXECUTION SYSTEMS

  • 9.1. Unmet Need for Manufacturing Execution Systems in the Healthcare Industry
  • 9.2. Key Assumptions and Methodology
  • 9.3. Key Tools and Technologies
    • 9.3.1. Technology 1
    • 9.3.2. Technology 2
    • 9.3.3. Technology 3
    • 9.3.4. Technology 4
  • 9.4. Extent of Innovation versus Associated Risks
  • 9.5. Concluding Remarks

10. MARKET FORECAST

  • 10.1. Key Assumptions and Forecast Methodology
  • 10.2. Forecasted Market Segments
  • 10.3. Manufacturing Execution System Providers in Healthcare Market, Till 2035
  • 10.4. Manufacturing Execution System Providers in Healthcare Market: Analysis by Type of Deployment, Till 2035
    • 10.4.1. Manufacturing Execution System Providers in Healthcare Market for Cloud Solutions
    • 10.4.2. Manufacturing Execution System Providers in Healthcare Market for Corporate Datacenter Solutions
    • 10.4.3. Manufacturing Execution System Providers in Healthcare Market for Hybrid Solutions
    • 10.4.4. Manufacturing Execution System Providers in Healthcare Market for On Premise Solutions
  • 10.5. Manufacturing Execution System Providers in Healthcare Market: Analysis by Type of End User, Till 2035
    • 10.5.1. Manufacturing Execution System Providers in Healthcare Market for Life science / Biotechnology Companies
    • 10.5.2. Manufacturing Execution System Providers in Healthcare Market for Medical Device Providers
    • 10.5.3. Manufacturing Execution System Providers in Healthcare Market for Pharmaceutical Companies
    • 10.5.4. Manufacturing Execution System Providers in Healthcare Market for Other End Users
  • 10.6. Manufacturing Execution System Providers in Healthcare Market: Analysis by Geography, Till 2035
    • 10.6.1. Manufacturing Execution System Providers in Healthcare Market in North America, Till 2035
    • 10.6.2. Manufacturing Execution System Providers in Healthcare Market in Europe, Till 2035
    • 10.6.3. Manufacturing Execution System Providers in Healthcare Market in Asia, Till 2035
    • 10.6.4. Manufacturing Execution System Providers in Healthcare Market in Latin America, Till 2035
    • 10.6.5. Manufacturing Execution System Providers in Healthcare Market in MENA, Till 2035
    • 10.6.6. Manufacturing Execution System Providers in Healthcare Market in Rest of the World, Till 2035

11. EXECUTIVE INSIGHTS

  • 11.1. Company A
    • 11.1.1. Company Snapshot
    • 11.1.2. Interview Transcript: Chief Executive Officer
  • 11.2. Company B
    • 11.2.1. Company Snapshot
    • 11.2.2. Interview Transcript: Chief Marketing Officer
  • 11.3. Company C
    • 11.3.1. Company Snapshot
    • 11.3.2. Interview Transcript: Director of Sales

12. APPENDICES I: OTHER FIGURES

12.1. Market Overview

  • 12.2. Key Insights
  • 12.3. Partnerships and Collaborations
  • 12.4. List of Figures

13. APPENDICES II: TABULATED DATA

14. APPENDICES III: LIST OF COMPANIES